As a professor of corporate strategy at Harvard Business School, worries over patent cliffs – when intellectual property rights for blockbuster drugs expire, causing revenues to collapse – and even US government fiscal cliffs are being replaced by the pressure of facing questions from bright young minds.

Read Now